Association Between Adducin-1 G460W Variant and Blood Pressure in Swedes Is Dependent on Interaction With Body Mass Index and Gender

American Journal of Hypertension

Volumn 20, Issue 9, 2007, Pages 981-989

  Fava, Cristiano ^a,b   Montagnana, Martina ^a,b   Almgren, Peter ^a   Rosberg, Lena ^a   Guidi, Gian Cesare ^b   Berglund, Göran ^a   Melander, Olle ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Adducin 1; blood pressure; genetics; hypertension; kidney

Indexed keywords

ACTIN BINDING PROTEIN; ADDUCIN; ANTIHYPERTENSIVE AGENT; PROTEIN ADDUCIN 1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENDER; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CALMODULIN-BINDING PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; POLYMORPHISM, GENETIC; SEX FACTORS; SWEDEN;

EID: 34548184589     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.04.007     Document Type: Article

References (30)

1. Menotti A., Lanti M., Kafatos A., Nissinen A., Dontas A., Nedeljkovic S., Kromhout D., and Study S.C. The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J Hypertens 22 (2004) 1683-1690
2. Melander O. Genetic factors in hypertension-what is known and what does it mean?. Blood Press 10 (2001) 254-270
3. Matsuoka Y., Li X., and Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci 57 (2000) 884-895
4. Tripodi G., Valtorta F., Torielli L., Chieregatti E., Salardi S., Trusolino L., Menegon A., Ferrari P., Marchisio P.C., and Bianchi G. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 97 (1996) 2815-2822
5. Bianchi G., Tripodi M.G., Casari G., Torielli L., Cusi D., Barlassina C., Stella P., Zagato L., and Barber B. Alpha-adducin may control blood pressure both in rats and humans. Clin Exp Pharmacol Physiol Suppl 22 (1995) S7-S9
6. Cusi D., Barlassina C., Azzani T., Casari G., Citterio L., Devoto M., Glorioso N., Lanzani C., Manunta P., Righetti M., Rivera R., Stella P., Troffa C., Zagato L., and Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 349 (1997) 1353-1357
7. Manunta P., Burnier M., D'Amico M., Buzzi L., Maillard M., Barlassina C., Lanella G., Cusi D., and Bianchi G. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33 (1999) 694-697
8. Manunta P., Cusi D., Barlassina C., Righetti M., Lanzani C., D'Amico M., Buzzi L., Citterio L., Stella P., Rivera R., and Bianchi G. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int 53 (1998) 1471-1478
9. Tripodi G., Florio M., Ferrandi M., Modica R., Zimdahl H., Hubner N., Ferrari P., and Bianchi G. Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats. Biochem Biophys Res Commun 324 (2004) 562-568
10. Ferrandi M., Salardi S., Tripodi G., Barassi P., Rivera R., Manunta P., Goldshleger R., Ferrari P., Bianchi G., and Karlish S. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Am J Physiol 277 (1999) H1338-H1349
11. Efendiev R., Krmar R.T., Ogimoto G., Zwiller J., Tripodi G., Katz A.I., Bianchi G., Pedemonte C.H., and Bertorello A.M. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 95 (2004) 1100-1108
12. Bianchi G., Ferrari P., and Staessen J. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension 45 (2005) 331-340
13. Larson N., Hutchinson R., and Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 35 (2000) 1297-1300
14. Glorioso N., Manunta P., Filigheddu F., Troffa C., Stella P., Barlassina C., Lombardi C., Soro A., Dettori F., Parpaglia P., Alibrandi M., Cusi D., and Bianchi G. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 34 (1999) 649-654
15. Ishikawa K., Katsuya T., Sato N., Nakata Y., Takami S., Takiuchi S., Fu Y., Higaki J., and Ogihara T. No association between alpha-adducin 460 polymorphism and essential hypertension in a Japanese population. Am J Hypertens 11 (1998) 502-506
16. Melander O., Bengtsson K., Orho-Melander M., Lindblad U., Forsblom C., Rastam L., Groop L., and Hulthen U.L. Role of the Gly460Trp polymorphism of the alpha-adducin gene in primary hypertension in Scandinavians. J Hum Hypertens 14 (2000) 43-46
17. Grant F.D., Romero J.R., Jeunemaitre X., Hunt S.C., Hopkins P.N., Hollenberg N.H., and Williams G.H. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 39 (2002) 191-196
18. Barlassina C., Schork N.J., Manunta P., Citterio L., Sciarrone M., Lanella G., Bianchi G., and Cusi D. Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 57 (2000) 1083-1090
19. Berglund G., Elmstahl S., Janzon L., and Larsson S.A. The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233 (1993) 45-51
20. Berglund G., Eriksson K.F., Israelsson B., Kjellstrom T., Lindgarde F., Mattiasson I., Nilsson J.A., and Stavenow L. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmo Preventive Project. J Intern Med 239 (1996) 489-497
21. Cifkova R., Erdine S., Fagard R., Farsang C., Heagerty A.M., Kiowski W., Kjeldsen S., Luscher T., Mallion J.M., Mancia G., Poulter N., Rahn K.H., Rodicio J.L., Ruilope L.M., van Zwieten P., Waeber B., Williams B., and Zanchetti A. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21 (2003) 1779-1786
22. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14 (1999) 143-149
23. Arcaro G., Zamboni M., Rossi L., Turcato E., Covi G., Armellini F., Bosello O., and Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 23 (1999) 936-942
24. Gerhard M., Roddy M.A., Creager S.J., and Creager M.A. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 27 (1996) 849-853
25. Redon J. Hypertension in obesity. Nutr Metab Cardiovasc Dis 11 (2001) 344-353
26. Rocchini A.P., Key J., Bondie D., Chico R., Moorehead C., Katch V., and Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321 (1989) 580-585
27. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., and Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
28. Pechere-Bertschi A., and Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 17 (2004) 994-1001
29. Taddei S., Virdis A., Ghiadoni L., Mattei P., Sudano I., Bernini G., Pinto S., and Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension 28 (1996) 576-582
30. Beeks E., van der Klauw M.M., Kroon A.A., Spiering W., Fuss-Lejeune M.J.M.J., and de Leeuw P.W. Alpha-adducin Gly460Trp polymorphism and renal hemodynamics in essential hypertension. Hypertension 44 (2004) 419-423